Ad therapeutics
12 Questions
3 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is the recommended pharmacological approach for people with mild to moderate Alzheimer's disease?

  • Memantine as a first-line treatment
  • No pharmacological treatment is recommended
  • Donepezil, galantamine, or rivastigmine as single agents (correct)
  • Donepezil, galantamine, or rivastigmine in combination with memantine
  • When should memantine be considered for people with Alzheimer's disease?

  • If they have mild disease and are not taking an AChE inhibitor
  • If they have severe disease and are taking an AChE inhibitor
  • If they have moderate disease and are intolerant or have a contraindication to an AChE inhibitor (correct)
  • If they have any severity of disease and are not taking an AChE inhibitor
  • What is the recommended approach for people with dementia with Lewy bodies who are intolerant to AChE inhibitors?

  • Do not consider any pharmacological treatment
  • Consider memantine as a first-line treatment
  • Consider galantamine only if donepezil and rivastigmine are not tolerated (correct)
  • Consider galantamine as a first-line treatment
  • What is the recommended approach for people with vascular dementia?

    <p>Offer AChE inhibitors or memantine only if they have suspected comorbid Alzheimer's disease, Parkinson's disease dementia or dementia with Lewy bodies</p> Signup and view all the answers

    What is the recommended approach for people with Alzheimer's disease who are already taking an AChE inhibitor and have severe disease?

    <p>Consider adding memantine to their treatment</p> Signup and view all the answers

    What is the recommended pharmacological approach for people with mild to moderate dementia with Lewy bodies?

    <p>Offer donepezil or rivastigmine as a first-line treatment</p> Signup and view all the answers

    What is the primary focus of the initial and ongoing management of non-cognitive symptoms in people living with dementia?

    <p>Psychosocial and environmental interventions</p> Signup and view all the answers

    In what circumstances can antipsychotics be offered to people living with dementia?

    <p>When there is a risk of harm to themselves or others, or when experiencing agitation, hallucinations, or delusions causing severe distress</p> Signup and view all the answers

    What should be considered when discussing antipsychotics with the person and their family members or carers?

    <p>Both the benefits and harms of antipsychotics</p> Signup and view all the answers

    What should be avoided in people living with dementia, due to the increased risk of stroke and death?

    <p>Antipsychotics for mild to moderate non-cognitive symptoms</p> Signup and view all the answers

    What should be stopped if no clear ongoing benefit is seen, and after discussion with the person and their family members or carers?

    <p>Antipsychotics</p> Signup and view all the answers

    What is not recommended for managing agitation or aggression in people living with dementia, unless indicated for another condition?

    <p>Valproate</p> Signup and view all the answers

    More Like This

    Alzheimer's Disease and Dementia
    10 questions

    Alzheimer's Disease and Dementia

    AccessibleCarnelian3863 avatar
    AccessibleCarnelian3863
    Alzheimer's Disease Medications Quiz
    48 questions

    Alzheimer's Disease Medications Quiz

    InviolableChrysoprase5995 avatar
    InviolableChrysoprase5995
    Use Quizgecko on...
    Browser
    Browser